Equity Components [Axis]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Ownership [Axis]
MDB Capital Holdings LLC [Member]
Statistical Measurement [Axis]
Minimum [Member]
Legal Entity [Axis]
Department of Energy [Member]
National Science Foundation [Member]
National Institute of Health [Member]
Product and Service [Axis]
Grant [Member]
Intangible Asset, Finite-Lived, Class [Axis]
Patents [Member]
Related and Nonrelated Parties [Axis]
Fair Value Hierarchy and NAV [Axis]
Fair Value, Inputs, Level 1 [Member]
Financial Instrument [Axis]
Cash and Cash Equivalents [Member]
Fair Value, Inputs, Level 2 [Member]
Fair Value, Inputs, Level 3 [Member]
Warrant [Member]
Long-Lived Asset, Class [Axis]
Laboratory Equipment [Member]
Furniture and Fixtures [Member]
Leasehold Improvements [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Subscription Agreement [Member]
Funding Warrant [Member]
Investor [Member]
Private Warrant [Member]
Maximum [Member]
Underwriters [Member]
Sale of Stock [Axis]
IPO [Member]
Scenario [Axis]
Forecast [Member]
Class of Warrant or Right [Axis]
Offering Warrant [Member]
Plan Name [Axis]
2020 Plan [Member]
Award Type [Axis]
2025 Equity Incentive Plan [Member]
Option Holders [Member]
Exercise Price Range [Axis]
Exercise Price One [Member]
Exercise Price Two [Member]
Option Indexed to Issuer's Equity, Type [Axis]
Share-Based Payment Arrangement, Option [Member]
Restricted Stock Units (RSUs) [Member]
Award Date [Axis]
July 19, 2021 [Member]
March 28, 2022 [Member]
May 1, 2023 [Member]
Lock Up Agreement [Member]
Antidilutive Securities [Axis]
Licensed Product [Member]
License Agreement [Member]
Second Licensed Product [Member]
Lease Agreement [Member]
Underwritten Public Offering Including Over Allotment [Member]
Registered Direct Offering [Member]
Underwritten Public Offering [Member]
Investor Warrants [Member]
Investor Warrant [Member]
Compensation Warrants [Member]
Valuation Approach and Technique [Axis]
Valuation Technique, Black-Scholes-Merton Model [Member]
Measurement Input Type [Axis]
Measurement Input, Price Volatility [Member]
Measurement Input, Risk Free Interest Rate [Member]
Measurement Input, Expected Term [Member]
Measurement Input, Expected Dividend Rate [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Statement of Financial Position [Abstract]
ASSETS
Cash and cash equivalents
Grants receivable
Due from affiliates
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Operating lease right-of-use asset, net
Finance lease right-of-use asset, net
Tax Receivable
Total assets
LIABILITIES AND EQUITY
Accounts payable
Due to affiliates
Operating lease liabilities – Current
Finance lease liabilities – Current
Total current Liabilities
Deferred grant reimbursement
Warrant Liability
Operating lease liabilities - Long term
Finance lease liabilities - Long term
Total liabilities
Stockholders’ Equity:
Preferred stock, $0.000001 par value, 5,000,000 shares authorized; no shares issued and outstanding on June 30, 2026, and December 31, 2025, respectively.
Common shares, 100,000,000 authorized shares at $0.000001; 9,281,359 and 8,406,681 shares issued and outstanding as of June 30, 2026, and December 31, 2025, respectively
Additional Paid-in-capital
Accumulated deficit
Total equity
Total liabilities and equity
Preferred stock, par value
Preferred stock, shares authorized
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, shares authorized
Common stock, par value
Common stock, shares issued
Common stock, shares outstanding
Income Statement [Abstract]
Total operating income
Operating costs:
General and administrative costs:
Compensation
Professional fees
Information technology
General and administrative-other
Total general and administrative costs
Research and development costs
Total operating costs
Net operating loss
Other income/(expense):
Interest income, net
Offering costs
Change in fair value of derivative instruments
Other income
Loss before income taxes
Income tax expense
Net loss
Net loss per common share - basic
Net loss per common share - diluted
Weighted average of common shares outstanding - basic
Weighted average of common shares outstanding - diluted
Statement [Table]
Statement [Line Items]
Beginning alance
Balance, shares
Stock-based compensation
Issuance of common stock due to vesting of RSU
Issuance of common stock due to vesting of RSU, shares
Issuance of common stock for exercise of options
Issuance of Common stock for exercise of options, shares
Net loss
Issuance of common stock in public offering
Issuance of common stock in public offering, shares
Issuance of common stock in registered direct offering
Issuance of common stock in registered direct offering, shares
Issuance of common stock for compensation
Issuance of common stock for compensation, shares
Stock options
Related Party Debt Forgiveness
Ending Balance
Balance, shares
Statement of Cash Flows [Abstract]
CASH FLOWS FROM OPERATING ACTIVITIES:
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of Deferred Grant Reimbursement
Depreciation of property and equipment
Change in fair value of derivative instruments
Non-cash lease expense
Stock-based compensation
Changes in operating assets and liabilities:
Grants receivable
Due from related party
Prepaid expenses and other current assets
Accounts payable and accrued expenses
Due to related party
Net cash (used in) operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Deferred grant reimbursement
Purchases of property and equipment
Net cash provided by (used in) investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Net proceeds from issuance of common stock and warrants
Payments on finance lease obligations
Net cash provided by financing activities
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD
CASH AND CASH EQUIVALENTS - END OF PERIOD
Supplemental disclosures of cash flow information:
Interest Expense
Non-cash investing and financing activities:
Forgiveness of debt
Accounting Policies [Abstract]
Organization and Description of Business
Summary of Significant Accounting Policies
Equity [Abstract]
Equity
Stock-Based Compensation
Earnings Per Share [Abstract]
Earnings Per Share
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies
Retirement Benefits [Abstract]
Employee Benefit Plans
Exclusive License Agreement
Exclusive License Agreement (eXoZymes)
Leases
Leases
Income Tax Disclosure [Abstract]
Income Taxes
Stockholders Equity Equity Offerings And Warrants
Stockholders’ Equity: Equity Offerings and Warrants
Subsequent Events [Abstract]
Subsequent Events
Basis of Presentation and Principles of Consolidation
Use of Estimates
Recent Accounting Pronouncements
Emerging Growth Company
Concentration of Risk
Revenue Recognition
Cash and Cash Equivalents
Fair Value Measurements
Property and Equipment
Research Grants
Research and Development Costs
Patent and Licensing Legal and Filing Fees and Costs
Related Party and Due to Affiliates Expenses
Segment Reporting
Schedule of Financial Instruments Measured at Fair Value on Recurring Basis
Schedule of Property and Equipment Estimated Useful Lives
Schedule of Property and Equipment
Schedule of Grants Receivable Activity
Schedule of Warrant Outstanding Issued Exercised and Expired
Schedule of Stock Option Grants
Schedule of Stock Options Activity
Schedule of Restricted Stock Units Activity
Schedule of Basic and Diluted Earnings (Loss) Per Share
Schedule of Anti-dilutive Loss Per Share
Schedule of Operating Leases
Schedule of Future Payments Due Under Operating and Finance Leases
Schedule of Offerings
Schedule of Fair Value Hierarchy for Investor Warrant Liability Recurring Fair Value Measurement
Fair Value Measurement Inputs and Valuation Techniques
Schedule of fair value of Investor Warrant liability
Property, Plant, and Equipment [Table]
Property, Plant, and Equipment [Line Items]
Minority ownership percentage
Net losses
Cash used for operations
Defined Benefit Plan [Table]
Defined Benefit Plan Disclosure [Line Items]
Total fair value
Total liabilities
Estimated useful lives
Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]
Total property and equipment
Less: Accumulated depreciation
Property and equipment, net
Balance at beginning of period
Grant costs expensed
Grants for equipment purchased
Grant fees
Grant funds received
Balance at end of period
Nature of Operation, Product Information, Concentration of Risk [Table]
Product Information [Line Items]
Grant reimbursements percentage
FDIC insurance limits
SIPC insurance limits
Cash, uninsured amount
Grant awarded value
Total grants value
Grant drawdowns
Grant drawdowns
Research and development costs
Legal fees
Outstanding payable
Number of reportable segment
WarrantOutstandingIssuedExercisedAndExpiredTable [Table]
Number of warrants outstaning, Balance
Weighted average exercise price, Balance
Expiration date
Number of warrants, Issued
Weighted average exercise price, issued
Expiration Date, Issued
Number of warrants, Exercised
Number of warrants, Expired
Number of warrants outstaning, Balance
Weighted average exercise price, Balance
Accumulated Other Comprehensive Income (Loss) [Table]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued
Value of shares issued
Exercise price per share
Warrants to purchase shares
Warrants vested
Total value of funding warrants
Shares issuable upon exercise of warrants
Warrants exercise price
Gross proceeds from private offering
Proceeds from warrants exercise
Warrants issued
Warrant term
Sale of Stock, Price Per Share
Stock isssued
Proceeds from Issuance of Warrants
Additional Paid in Capital, Common Stock
Warrant expire date
Shares Granted
Exercise Price
Vesting Term
Expected Life
Risk Free Rate
Expected Volatility
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Shares, Stock Options Outstanding, Balance
Weighted Average Exercise Price Stock Options Outstanding, Balance
Weighted Average Remaining Contractual Life, Stock Options Outstanding
Number of Shares, Granted
Weighted Average Exercise Price, Granted
Weighted Average Remaining Contractual Life, Granted
Number of Shares, Exercised
Weighted Average Exercise Price, Exercised
Weighted Average Remaining Contractual Life, Exercised
Number of Shares, Expired
Weighted Average Exercise Price, Expired
Number of Shares, Forfeited/Cancelled
Weighted Average Exercise Price, Forfeited/Cancelled
Weighted Average Remaining Contractual Life, Forfeited/Cancelled
Number of Shares, Stock Options Outstanding, Balance
Weighted Average Exercise Price Stock Options Outstanding, Balance
Number of Shares Stock options exercisable Outstanding
Weighted Average Exercise Price, Exercisable
Weighted Average Remaining Contractual Life, exercisable
Number of Restricted Stock Units, Outstanding, Beginning
Weighted Average Grant Date Fair Value, Outstanding, Beginning
Weighted Average Remaining Contractual Life, Outstanding
Number of Restricted Stock Units, Granted
Weighted Average Grant Date Fair Value, Granted
Weighted Average Remaining Contractual Life, Granted
Number of Restricted Stock Units, Exercised
Weighted Average Grant Date Fair Value, Exercised
Weighted Average Remaining Contractual Life, Expired
Number of Restricted Stock Units, Forfeited
Weighted Average Grant Date Fair Value, Forfeited
Number of Restricted Stock Units, Outstanding, Ending
Weighted Average Grant Date Fair Value, Outstanding, Ending
Number of Restricted Stock Units, Vested
Weighted Average Grant Date Fair Value, Vested
Weighted Average Remaining Contractual Life, Vested
Shares authorized for issuance
Unrecognized stock-based compensation
Weighted average remaining contractual term
Dividend yield
Stock options, exercised
Exercise price
Shares withheld
Shares issued upon exercise
Unvested options outstanding
Exercise price of options exercised
Stock option exercise price share
Stock option vested
Stock option exercise price
Stock option intrinsic value
Vesting period
Stock option expiration term
Restricted stock units granted
Restricted stock value per share
Expiration date
Stock expenses
Unrecognized stock-based compensation
Weighted average remaining life, exercisable
Restricted stock units
Options exercised
Options vested
Weighted average shares outstanding - basic
Net loss per share - basic
Net loss per share - diluted
Antidilutive Security, Excluded EPS Calculation [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total
Antidilutive securities, shares
Post employment benefit
ExclusiveLicenseAgreementTable [Table]
ExclusiveLicenseAgreementLineItems [Line Items]
Payment for licensed product
Cumulative net sales
Payments for patent fees
License fees paid
Schedule Of Operating Leases
Right-of-use assets
Operating lease liabilities
Weighted average remaining lease term in years
Weighted average discount rate
Cash paid for amounts included in the measurement of lease liabilities
Right-of-use assets
Finance lease liabilities
Weighted average remaining lease term in years
Weighted average discount rate
Amortization of assets under finance lease
Interest
Schedule Of Future Payments Due Under Operating And Finance Leases
Operating Lease
2026 Operating Leases
2027 Operating Leases
2028 Operating Leases
2029 Operating Leases
Total Operating Leases
Less effects of discounting Operating Leases
Total operating lease liabilities
Finance Lease
2026 Finance Leases
2027 Finance Leases
2028 Finance Leases
2029 Finance Leases
Total Finance Leases
Less effects of discounting Finance Leases
Total Finance Leases liabilities
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Variable lease cost
Operating lease term
Rent per month
Base rent paid in final year
Operating cost percenatge
Current lease
Current leased space amount
Rent per month in final year
Current lease in final year
Current leased space amount in final year
Fair value of lease equipment
Assumed rate percentage
Present value of assets
Percentage of assets fair value
Operating lease cost
Finance lease payments
Effective tax rate
Federal statutory rate
Federal income tax returns
OfferingsTable [Table]
Subsidiary, Sale of Stock [Line Items]
Common shares
Investor warrants
Gross proceeds
Net proceeds
StockholdersEquityTable [Table]
StockholdersEquityLineItems [Line Items]
Public offering price per share
Gross proceeds
Net proceeds
Warrant to purchase shares
Investor warrant price per share
Expire date
Common stock percentage
Sale of stock price per share
Fair value expected volatility
Fair value risk-free interest rate
Fair value expected term
Warrant liability decreased
Investor Warrant liability, At issuance
Investor Warrant liability
Fair Value Measurement Inputs and Valuation Techniques [Table]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input
Schedule Of Fair Value Of Investor Warrant Liability
Beginning balance
Issuance
Change in fair value
Ending balance, June 30, 2026
Stock issued during period value issuance of warrants in direct offering.
Offering costs accrued noncash.
Noncash grant reimbursement.
Forgiveness of debt noncash.
Deferred grant reimbursement.
MDB Capital Holdings LLC [Member]
Emerging Growth Company [Policy Text Block]
Research Grants [Policy Text Block]
Related Party Expenses [Policy Text Block]
Government grant reimbursements percentage.
Department of Energy [Member]
National Institute of Health [Member]
National Science Foundation [Member]
Cash SIPC insured amount.
Schedule of Property Plant and Equipment Estimated Useful Lives [Table Text Block]
Laboratory Equipment [Member]
Schedule Of Grants Receivable [Table Text Block]
Grant costs expensed.
Grant fees.
Grant funds received.
Grants for equipment purchased.
Grant awarded value.
Grants value.
Grant drawdowns.
Research and development costs.
SubscriptionAgreementMember
Funding Warrant [Member]
Share based payment award nonoption vested number of shares.
Private Warrant [Member]
Underwriters [Member]
Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price.
Warrants expiration term.
Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price per share issued.
Issued warrants expiration term.
2020 Plan [Member]
2025 Equity Incentive Plan [Member]
Option Holders [Member]
Exercise Price One [Member]
Exercise Price Two [Member]
Share based compensation arrangement by share based payment award options granted weighted average remaining contractual term 2.
Share based compensation arrangement by share based payment award options exercised weighted average remaining contractual term.
Share based compensation arrangement by share based payment award options forfeited and cancelled weighted average remaining contractual term.
July 19, 2021 [Member]
March 28, 2022 [Member]
May 1, 2023 [Member]
Share based compensation arrangement by share based payment award equity instrument other than options expired weighted average remaining contractual terms.
Share based compensation arrangement by share based payment award equity instruments other than options non vested.
Lock Up Agreement [Member]
Share based compensation arrangement by share based payment award equity instruments other than options exercised in period.
Share based compensation arrangement by share based payment award equity instruments other than options vested.
Share based compensation arrangement by share based payment award equity instruments other than options expired in period weighted average grant date fair value.
The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.
Share based compensation arrangement by share based payment award equity instruments other than options outstanding weighted average remaining contractual expired terms.
Share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average remaining contractual terms.
Share based compensation arrangement by share based payment award equity instruments other than options outstanding weighted average remaining contractual granted.
Increase decrease in due from related party.
Exclusive License Agreement Disclosure [Text Block]
Payments to acquire licensed product.
Licensed Product [Member]
License Agreement [Member]
Cumulative net sales.
Second Licensed Product [Member]
Payment for license fees.
Base rent paid in final year.
Lease Agreement [Member]
Operating cost percenatge.
Current leased space amount.
Payments for rent in final year.
Current lease in final year.
Current leased space amount in final year.
Percentage of assets fair value.
Stockholders Equity Equity Offerings and Warrants [Text Block]
Schedule of Offerings [Table Text Block]
Investor Warrants [Member]
Investor warrants issued
Underwritten Public Offering Including Over Allotment [Member]
Registered Direct Offering [Member]
Underwritten Public Offering [Member]
Investor Warrant [Member]
Compensation Warrants [Member]
Class of warrant or rights date from which warrants or rights expire.
Offering Warrant [Member]
Related party debt forgiveness
Non cash lease expense
Warrant liability noncurrent.
Offering costs.
Sharebased compensation arrangement by sharebased payment award equity instruments other than options vested weighted average grant date fair value.
Sharebased compensation arrangement by sharebased payment award equity instruments other than options vested weighted average remaining contractual terms.
Finance lease payments.
Useful Life, Shorter of Lease Term or Asset Utility [Member]
Assets, Current
Assets
Liabilities, Current
Liabilities
Equity, Attributable to Parent
Liabilities and Equity
General and Administrative Expense
Operating Costs and Expenses
Operating Income (Loss)
OfferingCosts
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Shares, Outstanding
Share-Based Payment Arrangement, Noncash Expense
Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Prepaid Expense and Other Assets
DeferredGrantReimbursement
Payments to Acquire Property, Plant, and Equipment
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Finance Lease, Principal Payments
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Lessee, Operating Leases [Text Block]
Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization
ResearchAndDevelopmentCosts
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualGranted
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date
Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount
Finance Lease, Weighted Average Remaining Lease Term
Finance Lease, Weighted Average Discount Rate, Percent
Lessee, Operating Lease, Liability, to be Paid
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Finance Lease, Liability, to be Paid
Finance Lease, Liability, Undiscounted Excess Amount
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value